that of larger effectivity in well being spending” | EUROtoday

LFrance at present devotes 12% of its gross home product (GDP) to financing well being spending, or greater than 300 billion euros per 12 months. Since the Seventies, these bills have elevated by 130%. This enhance has been very useful for the French: in reality, there’s a robust correlation between the expansion price of well being spending and the good points in life expectancy of the populations who profit from it.

Historically, well being spending follows financial progress. In an ideal world, a virtuous circle begins: spending helps enhance the well being of the inhabitants, and the ensuing productiveness good points gasoline financial progress, as a result of there’s a direct hyperlink between well being, schooling and productiveness. of labor. This progress then makes it potential to extend funding in well being. And so on…

In occasions of disaster, well being spending decreases much less rapidly than GDP, as a result of the social safety system performs its function as a shock absorber. The financing of well being expenditure then entails debt which, by making it potential to take care of funding within the well being system, creates favorable situations for the resumption of financial progress. But three causes make this restoration situation unsure at present.

The decline within the attractiveness of the French marketplace for producers

First of all, a rising share of well being spending is allotted to financing the wants of dependent aged individuals, whose contribution to financial progress is a priori lowered. Then, the very degraded monetary state of affairs of the hospital and the scarcity of care provision result in large long-term funding wants, on the very time when the rise in rates of interest is deteriorating debt situations. Finally, drug improvements coming into the market have costs negotiated at unprecedented ranges, which compromises the system’s capacity to finance entry.

Our well being insurance policies are at the moment responding to those challenges by activating two essential levers: the rise within the contribution of producers and personal insurers to the financing of Health Insurance bills, and the rise within the the rest payable by sufferers. These two levers are much more highlighted by the 2025 Social Security financing invoice (PLFSS).

In a context the place the French market represents solely 3% of the worldwide drug market, this technique might finally contribute to decreasing entry to take care of French sufferers. Indeed, regulatory instruments such because the “safeguard clause” or drug delistings scale back the attractiveness of the French marketplace for producers, who danger favoring entry into extra buoyant markets.

You have 53.31% of this text left to learn. The relaxation is reserved for subscribers.